Is Neurofeedback Safe During Perimenopause?

A woman in a cozy green sweater sits beside a mountain lake at sunset, resting her chin on her hand and looking thoughtfully toward the mountains and water.

You know what it’s like navigating the unpredictability of perimenopause… fluctuating hormones, disrupted sleep, feeling perpetually on edge, feeling like you can’t remember anything. During perimenopause the last thing you want is to add something to your life that might make things worse. If you’ve been considering neurofeedback and your first question is “but is it actually safe?”, you aren’t alone. And that’s exactly the right question to ask.

The short answer is for many women neurofeedback is safe. But a short answer isn’t enough when you’re making decisions about your own health. This post will give you the full picture: what neurofeedback does and doesn’t do to the brain, what the research says about safety, what side effects are possible and how common they are, and what to look for in a practitioner to ensure you’re in safe hands.

What Neurofeedback Actually Is – and Isn’t

A great deal of the uncertainty around neurofeedback’s safety stems from misunderstanding what it actually involves. So let’s be completely clear.

Neurofeedback measures the brain’s electrical activity using sensors placed on the scalp. These sensors only read brain activity. They do not transmit anything into the brain. There is no electrical current delivered to your head. There are no needles, no invasive procedures, no drugs, and no anesthesia.

What neurofeedback does is show the brain a real-time reflection of its own activity, usually through a video or audio signals. The brain knows when it produces more desirable brain wave patterns because the video or auditory signals are present. The goal is to give the brain information about its own activity and through repeated practice and feedback, it learns to regulate certain patterns of activity more effectively.

This is fundamentally different from other brain-based interventions that stimulate the brain such as transcranial magnetic stimulation (TMS) or transcranial direct current stimulation (tDCS). Those carry their own safety profiles and considerations. Neurofeedback does not involve these mechanisms because there is no transmission into the brain.

The Safety Record: What the Research Shows

Neurofeedback has been used clinically for over five decades, beginning with research in the 1960s and 1970s on SMR (sensorimotor rhythm) training and epilepsy. In that time, a substantial body of research and clinical experience has accumulated, and the overall safety record is very good.

The largest and most comprehensive reviews of neurofeedback safety consistently conclude:

  • Serious adverse effects appear to be uncommon
  • It is generally considered safe for use alongside other treatments, including hormone therapy, antidepressants, and other medications commonly used in perimenopause
  • There are no established contraindications specific to perimenopause identified in the literature

In short, research suggests that neurofeedback is well tolerated by most individuals.

Possible Side Effects: Honest and Complete

Saying neurofeedback is safe does not mean it is entirely without side effects. An honest account of what is possible, and how common each possibility is, is more useful than reassurance that glosses over reality.

Temporary Fatigue

Some people report temporary fatigue after neurofeedback sessions, particularly early in training. During session, the brain is receiving and processing continuous feedback and making subtle adjustments to its own activity. This can feel like mental exertion afterward, even though the session itself didn’t feel effortful.

Fatigue typically resolves within a few hours and tends to lessen as the course progresses and the brain becomes more accustomed to the training. For perimenopausal women who are already managing fatigue from disrupted sleep and hormonal change, this is worth knowing in advance. Scheduling sessions for times when you can rest afterward, at least early in treatment, is sensible planning.

Headache

Mild headaches are occasionally reported after sessions, again particularly in the early stages. These are typically tension-type and resolve without intervention; however, if you experience persistent or significant headaches, let your practitioner know.

What Doesn’t Happen

For clarity: neurofeedback does not cause seizures in people without pre-existing seizure disorders, and it does not change someone’s personality. Because neurofeedback is intended to train self-regulation, neurofeedback does not create dependency and there is no withdrawal if you stop. Furthermore, because the brain is not reliant on sessions to maintain the patterns it has learned, people do not need to continue treatment indefinitely.

Special Considerations for Perimenopause

While neurofeedback is safe during perimenopause, there are several considerations specific to this life stage that a good practitioner should consider.

A Neurological System Already in Transition

The perimenopausal brain is already adapting to changing hormone levels. These changes can affect brain function, sleep, mood, and other symptoms. These symptoms can change throughout the menopausal transition so your response to neurofeedback may also change. Because of this, practitioners should continually monitor how someone is responding and adjust the training when appropriate.

Interaction with Hormone Therapy

Utilizing hormone therapy (MHT) does not automatically mean you cannot receive neurofeedback. Hormone therapy stabilizes the neurochemical environment while neurofeedback trains the brain’s electrical self-regulation. Together they can work together to help support the perimenopause transition.

If you start hormone therapy during a course of neurofeedback, or adjust your dose, inform your practitioner. Hormonal changes can shift brainwave patterns which may require an adjustment to your protocol.

Medication Interactions

Neurofeedback does not involve introducing a medication or other drug into the body, so it does not have the same type of drug–drug interactions as medications. However, some medications can affect alertness, sleep, arousal, or EEG activity, which may be relevant when interpreting brain activity and monitoring your response to training.

This doesn’t mean you should stop medications before beginning neurofeedback. Never change medications without your prescribing physician’s guidance. Furthermore, it doesn’t mean you may not be a candidate for neurofeedback. What it does mean is that your neurofeedback practitioner and your prescribing physician should be aware of each other’s involvement in your care, and that the practitioner should be informed of all medications when designing your protocol.

Who Should Exercise Caution or Seek Extra Guidance

While neurofeedback is broadly safe during perimenopause, there are situations where extra care, consultation, or specialist input is warranted before beginning:

  • Active seizure disorders: Neurofeedback has been used therapeutically to reduce seizure frequency, but it should only be used with this population by a practitioner with specific expertise in epilepsy neurofeedback. If you have a seizure disorder, discuss neurofeedback with your neurologist and work with a practitioner experienced in this population.
  • Recent concussion or traumatic brain injury: If you have recently experienced a concussion or traumatic brain injury, discuss the timing and appropriateness of neurofeedback with your healthcare provider and practitioner before beginning.
  • Acute psychiatric crisis: Neurofeedback is not an emergency intervention. If you are in an acute mental health crisis, including severe depression with suicidal ideation, psychosis, or acute severe anxiety, stabilization through appropriate clinical care should come first.

How to Ensure You’re in Safe Hands

The effectiveness of neurofeedback is significantly influenced by the skill, training, and ethical practice of the practitioner delivering it. A poorly designed protocol, inadequate monitoring, or a practitioner who fails to adjust training as needed can result in limited symptom relief and/or prolonged intervention.

When choosing a practitioner, look for:

  • Experience with perimenopausal or menopausal clients: Ask whether they have worked specifically with women navigating hormonal transitions, and what protocols they use for this population. Experience matters in a field where protocol design is highly individualized.
  • Appropriate training and experience: Ask how long the practitioner has provided neurofeedback, their background, training and experience, and how they utilize consultations with other providers.
  • Clear communication and monitoring: Your practitioner should explain what they are doing and why, track your responses session by session, and be responsive to any experiences you report (including any temporary worsening of symptoms). You should never feel in the dark about your own treatment.
  • Willingness to communicate with your other providers: A qualified neurofeedback practitioner should understand they are one part of your healthcare team. They should be comfortable sharing information with your gynecologist or prescribing physician as needed.

The Bottom Line

For most women, neurofeedback is safe during perimenopause. Its five-decade clinical history, absence of serious adverse effects, non-invasive mechanism, and compatibility with hormone therapy makes it an appropriate option for women navigating the challenges of the menopausal transition to explore.

While side effects do exist, they tend to be minor, transient, and manageable. They are not reasons to avoid treatment; they are things to be aware of and to discuss openly with your practitioner.

What neurofeedback offers perimenopausal women is a direct, non-pharmacological way to train the brain toward greater stability, resilience, and self-regulation. As a bonus this happens without adding more chemistry to an already shifting hormonal picture.

Have Questions About Neurofeedback and Perimenopause?

If you’re considering neurofeedback during perimenopause or menopause, you don’t have to figure it out on your own. We’re happy to answer your questions, talk through what you’re experiencing, and explain what neurofeedback involves so you can decide whether it may be appropriate for you.

Contact Northwest Neurofeedback to schedule your complementary 15-minute consultation or learn more about our approach to supporting brain health during the menopausal transition.

This article is for informational purposes only and does not constitute medical advice. If you are considering neurofeedback during perimenopause or menopause, discuss it with your healthcare provider and a qualified neurofeedback practitioner.